bullish
Concord Biotech IPO - Peer Comparison & Valuation - Smaller in Scale but Wider in Margins
582 Views04 Aug 2023 10:43
Concord Biotech Ltd (658823Z IN) is looking to raise around US$188m in its India IPO. In this note, we will undertake a peer comparison, and share our thoughts on valuation.
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 9-minute read)
Discussions
(Paid Plans Only)
- Concord Biotech IPO Trading - Strong Subscription Rates, Peers Have Moved up Since Last Note17 Aug 2023
- ECM Weekly (13th August 2023) - Zomato, TVS Supply Chain, Suzlon Energy, Star Asia Investment13 Aug 2023
- ECM Weekly (6th August 2023) - Concord Biotech, SBFC Fin, Fadu, Mitsui Fudosan, Capitaland Ascott06 Aug 2023
- Concord Biotech IPO - Peer Comparison & Valuation - Smaller in Scale but Wider in Margins04 Aug 2023
- Concord Biotech IPO - RHP Updates - Continued Growing Although Concentration Risk Remains Elevated02 Aug 2023
- Concord Biotech Pre-IPO - Sales Have Been Growing but Watch Out for Its High Concentration Risk30 Jan 2023
- Concord Biotech Pre-IPO Tearsheet24 Aug 2022
x